- Faculty
- Health
- In the News
EchoTip AcuCore EUS Biopsy Needle Post-Market Study
Jason Samarasena
A Study On:
- Cancer - Oncologic
- Pancreatitis
Status:
- Open
Eligibility
Adenocarcinoma
Neuroendocrine Tumors
Hepatocellular Carcinoma
Cholangiocarcinoma
Malignant Lymphoma
Metastasis
Chronic Pancreatitis
Autoimmune Pancreatitis
18 Years and older (Adult, Older Adult)
Interested in joining this trial?
Official Title
EchoTip AcuCore EUS Biopsy Needle Post-Market Study
Eligibility
You can join if...
Inclusion Criteria:
- Patient has been referred for an endoscopic ultrasound (EUS) fine needle biopsy procedure
- The EchoTip AcuCore device is the first EUS biopsy needle used in the procedure.
Exclusion Criteria:
- Patient's age is less than 18 years
- Patient is unable or unwilling to sign and date the informed consent. If IRB approves a waiver of consent, this exclusion criterion is not applicable.
- Patient is simultaneously participating in another pre-market investigational drug or pre-market investigational device study involving an EUS fine needle biopsy procedure and for which the patient has not completed the follow-up phase for the primary endpoint at least 30 days prior to enrollment in this study.
- Inaccessible or unsuitable lesion (lesion not visualized or a large vessel, duct or primary mass interposition)
Get in touch with our study team
News & Events
- Faculty
- Health
- In the News
- Faculty
- Health
- In the News